Literature DB >> 24316388

Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION).

Chung-Hsing Chang1, Tzu-Lun Huang2, Shun-Ping Huang3, Rong-Kung Tsai4.   

Abstract

The purpose of this study was to investigate the neuroprotective effects of recombinant human granulocyte colony stimulating factor (G-CSF), as administered in a rat model of anterior ischemic optic neuropathy (rAION). Using laser-induced photoactivation of intravenously administered Rose Bengal in the optic nerve head of 60 adult male Wistar rats, an anterior ischemic optic neuropathy (rAION) was inducted. Rats either immediately received G-CSF (subcutaneous injections) or phosphate buffered saline (PBS) for 5 consecutive days. Rats were euthanized at 4 weeks post infarct. Density of retinal ganglion cells (RGCs) was counted using retrograde labeling of Fluoro-gold. Visual function was assessed by flash visual-evoked potentials (FVEP) at 4 weeks. TUNEL assay in the retinal sections and immunohistochemical staining of ED1 (marker of macrophage/microglia) were investigated in the optic nerve (ON) specimens. The RGC densities in the central and mid-peripheral retinas in the G-CSF treated rats were significantly higher than those of the PBS-treated rats (survival rate was 71.4% vs. 33.2% in the central retina; 61.8% vs. 22.7% in the mid-peripheral retina, respectively; both p < 0.05). FVEP measurements showed a significantly better preserved latency and amplitude of the p1 wave in the G-CSF-treated rats than that of the PBS-treated rats (latency120 ± 11 ms vs. 142 ± 12 ms, p = 0.03; amplitude 50 ± 11 μv vs. 31 ± 13 μv, p = 0.04). TUNEL assays showed fewer apoptotic cells in the retinal ganglion cell layers of G-CSF treated rats [2.1 ± 1.0 cells/high power field (HPF) vs. 8.0 ± 1.5/HPF; p = 0.0001]. In addition, the number of ED1 positive cells was attenuated at the optic nerve sections of G-CSF-treated rats (16 ± 6/HPF vs. 35 ± 10/HPF; p = 0.016). In conclusion, administration of G-CSF is neuroprotective in the rat model of anterior ischemic optic neuropathy, as demonstrated both structurally by RGC density and functionally by FVEP. G-CSF may work via the dual actions of anti-apoptosis for RGC surviving as well as anti-inflammation in the optic nerves as evidenced by less infiltration of ED1-povitive cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  granulocyte colony stimulating factor; neuroprotection; rAION; rat anterior ischemic optic neuropathy; retinal ganglion cells

Mesh:

Substances:

Year:  2013        PMID: 24316388     DOI: 10.1016/j.exer.2013.11.012

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Progesterone treatment in two rat models of ocular ischemia.

Authors:  Rachael S Allen; Timothy W Olsen; Iqbal Sayeed; Heather A Cale; Katherine C Morrison; Yuliya Oumarbaeva; Irina Lucaciu; Jeffrey H Boatright; Machelle T Pardue; Donald G Stein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 2.  Efficacy of granulocyte-colony stimulating factor treatment in a rat model of anterior ischemic optic neuropathy.

Authors:  Shun-Ping Huang; Rong-Kung Tsai
Journal:  Neural Regen Res       Date:  2014-08-15       Impact factor: 5.135

3.  Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood-optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION).

Authors:  Yao-Tseng Wen; Tzu-Lun Huang; Sung-Ping Huang; Chung-Hsing Chang; Rong-Kung Tsai
Journal:  Dis Model Mech       Date:  2016-08-18       Impact factor: 5.758

4.  Soluble P-selectin promotes retinal ganglion cell survival through activation of Nrf2 signaling after ischemia injury.

Authors:  Kishan Kapupara; Yao-Tseng Wen; Rong-Kung Tsai; Shun-Ping Huang
Journal:  Cell Death Dis       Date:  2017-11-16       Impact factor: 8.469

5.  Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy.

Authors:  Wei Zhang; Yuexin Wang; Jiahui Kong; Meng Dong; Hongtao Duan; Song Chen
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

6.  Oroxylin A promotes retinal ganglion cell survival in a rat optic nerve crush model.

Authors:  Shu-Fang Lin; Jia-Ying Chien; Kishan Kapupara; Chi-Ying F Huang; Shun-Ping Huang
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

7.  Neuroprotective effects of low-dose G-CSF plus meloxicam in a rat model of anterior ischemic optic neuropathy.

Authors:  Pei-Kang Liu; Yao-Tseng Wen; Wei Lin; Kishan Kapupara; Minghong Tai; Rong-Kung Tsai
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

8.  Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION).

Authors:  Zuohuizi Yi; Liao Chen; Xiaoling Wang; Changzheng Chen; Yiqiao Xing
Journal:  J Ophthalmol       Date:  2020-07-07       Impact factor: 1.909

Review 9.  Translational Preclinical Research may Lead to Improved Medical Management of Non-Arteritic Anterior Ischemic Optic Neuropathy.

Authors:  James D Nicholson; Hana Leiba; Nitza Goldenberg-Cohen
Journal:  Front Neurol       Date:  2014-07-11       Impact factor: 4.003

10.  Did you choose appropriate tracer for retrograde tracing of retinal ganglion cells? The differences between cholera toxin subunit B and Fluorogold.

Authors:  Fei Yao; Endong Zhang; Zhaolin Gao; Hongpei Ji; Mahmoud Marmouri; Xiaobo Xia
Journal:  PLoS One       Date:  2018-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.